✦ LIBER ✦

Hyaluronic Acid- Paclitaxel: Antitumor Efficacy against CD44(+) Human Ovarian Carcinoma Xenografts

✍ Scribed by Auzenne, Edmond; Ghosh, Sukhen C.; Khodadadian, Mojgan; Rivera, Belinda; Farquhar, David; Price, Roger E.; Ravoori, Murali; Kundra, Vikas; Freedman, Ralph S.; Klostergaard, Jim

Book ID: 122139734
Publisher: Neoplasia Press
Year: 2007
Tongue: English
Weight: 374 KB
Volume: 9
Category: Article
ISSN: 1522-8002
DOI: 10.1593/neo.07229

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hyaluronic acid–paclitaxel: effects of i

Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts

✍ Ilaria De Stefano; Alessandra Battaglia; Gian Franco Zannoni; Maria Grazia Prisc 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 534 KB

Antitumor activity of paclitaxel against

Antitumor activity of paclitaxel against human breast carcinoma xenografts serially transplanted into nude mice

✍ Kubota, Tetsuro; Matsuzaki, Shinjiro Wilson; Hoshiya, Yasunori; Watanabe, Masahi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

Background: Paclitaxel (BMS-181339: Taxol) is a promising agent against previously treated breast cancer. The antitumor activity of paclitaxel was evaluated using five human breast carcinoma xenografts in nude mice. Methods: Paclitaxel at 20 mg/kg dissolved in 0.2 ml ethanol/cremophor EL solution wa

Oncocidin A1: a novel tubulin-binding dr

Oncocidin A1: a novel tubulin-binding drug with antitumor activity against human breast and ovarian carcinoma xenografts in nude mice

✍ Xiaoying Chen; Polly Pine; A.Merrill Knapp; Daniel Tusé; Keith R. Laderoute 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 686 KB